PharmaPure is a pharmaceutical standards and analytical services provider focused on supporting research, development, quality control, and regulatory compliance. The company supplies pharmaceutical impurity standards, pharmacopoeial and non-pharmacopoeial reference standards, and certified reference materials for active pharmaceutical ingredients and finished drug products. Its catalogue includes more than 1,800 synthesized impurities, including nitrosamine compounds, with custom synthesis available on request.

PharmaPure’s analytical services include method development and validation, pharmacopeial testing, impurity analysis, identification of unknown compounds, biosimilar analysis, and pharmaceutical formulation development. The company also offers impurity isolation and structure elucidation using techniques such as LC-MS, HPLC, NMR, FT-IR, and elemental analysis. Additional services include ICH M7 purge assessments for toxic compounds and virtual bioequivalence support.

For organizations seeking regulatory and technical guidance, PharmaPure provides consultations on quality systems, drug master files, authority responses, pharmaceutical R&D, bioanalysis, and biosimilars. Its training covers analytical methods, impurity analysis, nitrosamines, regulated laboratory practices, and GxP topics. These products and services serve pharmaceutical manufacturers, contract research organizations, and regulatory laboratories.